Skip to main content

Aeglea BioTherapeutics, Inc. - Common Stock (NQ: AGLE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 27, 2023 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
December 04, 2017
Form 4
Source: SEC/Edgar
December 04, 2017
Form 4
Source: SEC/Edgar
August 31, 2017
Form 4
Source: SEC/Edgar
August 23, 2017
Form 4
Source: SEC/Edgar
August 23, 2017
Form 4
Source: SEC/Edgar
August 23, 2017
Form 4
Source: SEC/Edgar
August 23, 2017
Form 4
Source: SEC/Edgar
August 23, 2017
Form 3
Source: SEC/Edgar
July 09, 2017
Form 4
Source: SEC/Edgar
April 24, 2017
Form 4
Source: SEC/Edgar
March 21, 2017
Form 4
Source: SEC/Edgar
March 21, 2017
Form 4
Source: SEC/Edgar
March 21, 2017
Form 4
Source: SEC/Edgar
March 21, 2017
Form 4
Source: SEC/Edgar
March 21, 2017
Form 4
Source: SEC/Edgar
February 20, 2017
Form 3
Source: SEC/Edgar
February 15, 2017
Form 4
Source: SEC/Edgar
February 15, 2017
Form 4
Source: SEC/Edgar
May 18, 2016
Form 4
Source: SEC/Edgar
May 18, 2016
Form 4
Source: SEC/Edgar
May 18, 2016
Form 4
Source: SEC/Edgar
May 18, 2016
Form 4
Source: SEC/Edgar
May 18, 2016
Form 4
Source: SEC/Edgar
May 18, 2016
Form 4
Source: SEC/Edgar
May 18, 2016
Form 3
Source: SEC/Edgar
May 18, 2016
Form 4
Source: SEC/Edgar
May 18, 2016
Form 4
Source: SEC/Edgar
May 18, 2016
Form 4
Source: SEC/Edgar
May 18, 2016
Form 3
Source: SEC/Edgar
April 18, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.